India Cancer Immunotherapy Market, By Type (Monoclonal Antibodies, Cancer Vaccines, Checkpoint Inhibitors, Immunomodulators), By Application (Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head and Neck Cancer, Others), By End U

India Cancer Immunotherapy Market, By Type (Monoclonal Antibodies, Cancer Vaccines, Checkpoint Inhibitors, Immunomodulators), By Application (Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head and Neck Cancer, Others), By End User Hospitals, Cancer Research Centers, Clinics), By Region (North India, South India, East India, West India), Trend Analysis, Competitive Landscape & Forecast, 2019–2030


India Cancer Immunotherapy Market Size Expands at Significant CAGR of 6.39% During 2024–2030, Reaching USD 102.11 Billion by 2030
India Cancer Immunotherapy Market is flourishing because of the increasing prevalence of cancer, government initiatives & funding, and rising healthcare expenditure.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the India Cancer Immunotherapy Market size at USD 98.37 billion in 2023. During the forecast period between 2024 and 2030, BlueWeave expects the India Cancer Immunotherapy Market size to grow at a significant CAGR of 6.39% reaching a value of USD 102.11 billion by 2030. As per the Indian Council of Medical Research – National Cancer Registry Programme (ICMR-NCRP), the estimated number of incidences of cancer cases in the country in 2022 was 14,61,427. Supportive government initiatives and funding for cancer research and treatment play a pivotal role. Investments in healthcare infrastructure and programs that promote immunotherapy adoption contribute to market growth. The Central Government has implemented the Strengthening of Tertiary Cancer Care Centres Facilities Scheme to improve cancer treatment facilities. The plan has approved 19 state cancer institutes (SCIs) and 20 tertiary care cancer centres (TCCCs). Increased healthcare spending, both by the government and individuals, fuels the adoption of advanced cancer treatments. This includes immunotherapies that offer promising outcomes in combating cancer

Opportunity: Advancements in Research and Development

Ongoing research and development activities in cancer immunotherapy provide prospects for the introduction of novel and more effective immunotherapeutic drugs. This may improve therapy options and outcomes for cancer patients in India. Novel therapy techniques, such as immune checkpoint inhibitors and adoptive cell treatments, are emerging as viable options for cancer patients in India. The Central Drugs Standard Control Organisation (CDSCO) has approved CAR-T (Chimeric Antigen Receptor-T) cell therapy, a ground-breaking treatment for relapsed/refractory (r/r) B-cell lymphomas and leukaemia, paving the way for the commercial launch of indigenous NexCAR19 in the country. ImmunoACT, an IIT Bombay incubated firm, developed the treatment.


Impact of Geopolitical Tension on India Cancer Immunotherapy Market

Geopolitical conflicts may cause interruptions in the pharmaceutical supply chain, compromising the availability of critical chemicals and medications. Political uncertainty may cause changes to regulatory frameworks, influencing medication approval processes and market access for immunotherapeutic treatments. Geopolitical instability may have an impact on foreign healthcare investments and funding, as well as cancer immunotherapy research and development initiatives. Political tensions can cause changes in trade policies, influencing the import and export of pharmaceutical products and potentially limiting access to cancer immunotherapies. Collaborations for multinational clinical trials, a critical part of drug development, may confront problems due to geopolitical tensions, affecting the progression of new cancer immunotherapy treatments.

India Cancer Immunotherapy Market – By End User

Based on end user, the India cancer immunotherapy market is segmented into hospitals, cancer research centers, and clinics. The hospital segment dominates the Indian cancer immunotherapy market. This is attributable to a number of variables, including a rise in the number of hospital admissions for cancer treatment, expanded hospital penetration across the country, and a greater preference for hospital care. Furthermore, the growing number of government and private hospitals, as well as the increasing use of cutting-edge technologies, add to hospitals' dominance in the cancer immunotherapy industry. Hospitals have the infrastructure and resources necessary to successfully deliver and monitor immunotherapy therapies.

India Cancer Immunotherapy Market – By Region

Regionally, the India Cancer Immunotherapy Market is segmented as North India, South India, East India, and West India. North India is expected to grow during the forecast period. North India, particularly Delhi and surrounding regions, boasts advanced healthcare infrastructure with leading hospitals and research centers. This facilitates the adoption and accessibility of cancer immunotherapy treatments. North India attracts a significant number of medical tourists seeking specialized cancer treatments, including immunotherapy. The presence of renowned healthcare institutions contributes to the region's dominance.

Competitive Landscape

Major players operating in the India Cancer Immunotherapy Market include Astellas Pharma Inc., AstraZeneca, Bayer AG, Bristol-Myers Squibb, Lilly, F. Hoffmann-La Roche Ltd, Merck & Co., Inc., Novartis AG, Pfizer Inc., Gilead Sciences, Inc, GSK plc, Johnson & Johnson, Sanofi. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of India Cancer Immunotherapy Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in India Cancer Immunotherapy Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.


1. Research Framework
1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation
2. Executive Summary
3. India Cancer Immunotherapy Market Insights
3.1. Industry Value Chain Analysis
3.2. DROC Analysis
3.2.1. Growth Drivers
3.2.1.1. Increasing cancer incidence
3.2.1.2. Government initiatives and funding
3.2.1.3. Collaborations and partnerships
3.2.2. Restraints
3.2.2.1. High treatment costs
3.2.2.2. Stringent regulatory requirements and approval processes
3.2.2.3. Side effects and safety concerns
3.2.3. Opportunities
3.2.3.1. Advancements in research and development
3.2.3.2. Patient awareness and education
3.2.4. Challenges
3.2.4.1. Infrastructure and expertise
3.2.4.2. Resistance mechanisms
3.3. Technology Advancements/Recent Developments
3.4. Regulatory Framework
3.5. Porter’s Five Forces Analysis
3.5.1. Bargaining Power of Suppliers
3.5.2. Bargaining Power of Buyers
3.5.3. Threat of New Entrants
3.5.4. Threat of Substitutes
3.5.5. Intensity of Rivalry
4. India Cancer Immunotherapy Market: Marketing Strategies
5. India Cancer Immunotherapy Market Overview
5.1. Market Size & Forecast, 2019-2030
5.1.1. By Value (USD Billion)
5.2. Market Share & Forecast
5.2.1. By Type
5.2.1.1. Monoclonal Antibodies
5.2.1.2. Cancer Vaccines
5.2.1.3. Checkpoint Inhibitors
5.2.1.4. Immunomodulators
5.2.2. By Application
5.2.2.1. Lung Cancer
5.2.2.2. Breast Cancer
5.2.2.3. Colorectal Cancer
5.2.2.4. Melanoma
5.2.2.5. Prostate Cancer
5.2.2.6. Head and Neck Cancer
5.2.2.7. Others
5.2.3. By End User
5.2.3.1. Hospitals
5.2.3.2. Cancer Research Centers
5.2.3.3. Clinics
5.2.4. By Region
5.2.4.1. North India
5.2.4.2. South India
5.2.4.3. East India
5.2.4.4. West India
6. North India Cancer Immunotherapy Market
6.1. Market Size & Forecast, 2019-2030
6.1.1. By Value (USD Billion)
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By Application
6.2.3. By End User
7. South India Cancer Immunotherapy Market
7.1. Market Size & Forecast, 2019-2030
7.2. By Value (USD Billion)
7.3. Market Share & Forecast
7.3.1. By Type
7.3.2. By Application
7.3.3. By End User
8. East India Cancer Immunotherapy Market
8.1. Market Size & Forecast, 2019-2030
8.2. By Value (USD Billion)
8.3. Market Share & Forecast
8.3.1. By Type
8.3.2. By Application
8.3.3. By End User
9. West India Cancer Immunotherapy Market
9.1. Market Size & Forecast, 2019-2030
9.1.1. By Value (USD Billion)
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Application
9.2.3. By End User
10. Competitive Landscape
10.1. List of Key Players and Their Offerings
10.2. India Cancer Immunotherapy Company Market Share Analysis, 2023
10.3. Competitive Benchmarking, By Operating Parameters
10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
11. Impact of Geopolitical Tension in India Cancer Immunotherapy Market
12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)
12.1. Astellas Pharma Inc.
12.2. AstraZeneca
12.3. Bayer AG
12.4. Bristol-Myers Squibb
12.5. Lilly
12.6. F. Hoffmann-La Roche Ltd
12.7. Merck & Co., Inc.
12.8. Novartis AG
12.9. Pfizer Inc.
12.10. Gilead Sciences, Inc
12.11. GSK plc
12.12. Johnson & Johnson
12.13. Sanofi
12.14. Other Prominent Players
13. Key Strategic Recommendations
14. Research Methodology
14.1. Qualitative Research
14.1.1. Primary & Secondary Research
14.2. Quantitative Research
14.3. Market Breakdown & Data Triangulation
14.3.1. Secondary Research
14.3.2. Primary Research
14.4. Breakdown of Primary Research Respondents, By Region
14.5. Assumptions & Limitations
*Financial information of case of non-listed companies can be provided as per availability.
**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable
List of Figures
Figure 1 India Cancer Immunotherapy Segmentation
Figure 2 India Cancer Immunotherapy Market Value Chain Analysis
Figure 3 Company Market Share Analysis, 2023
Figure 4 India Cancer Immunotherapy Market Size, By Value (USD Billion), 2019-2030
Figure 5 India Cancer Immunotherapy Market Share, By Type, By Value, 2019-2030
Figure 6 India Cancer Immunotherapy Market Share, By Application, By Value, 2019-2030
Figure 7 India Cancer Immunotherapy Market Share, By End User, By Value, 2019-2030
Figure 8 India Cancer Immunotherapy Market Share, By Region, By Value, 2019-2030
Figure 9 North India Cancer Immunotherapy Market Size, By Value (USD Billion), 2019-2030
Figure 10 North India Cancer Immunotherapy Market Share, By Type, By Value, 2019-2030
Figure 11 North India Cancer Immunotherapy Market Share, By Application, By Value, 2019-2030
Figure 12 North India Cancer Immunotherapy Market Share, By End User, By Value, 2019-2030
Figure 13 South India Cancer Immunotherapy Market Size, By Value (USD Billion), 2019-2030
Figure 14 South India Cancer Immunotherapy Market Share, By Type, By Value, 2019-2030
Figure 15 South India Cancer Immunotherapy Market Share, By Application, By Value, 2019-2030
Figure 16 South India Cancer Immunotherapy Market Share, By End User, By Value, 2019-2030
Figure 17 East India Cancer Immunotherapy Market Size, By Value (USD Billion), 2019-2030
Figure 18 East India Cancer Immunotherapy Market Share, By Type, By Value, 2019-2030
Figure 19 East India Cancer Immunotherapy Market Share, By Application, By Value, 2019-2030
Figure 20 East India Cancer Immunotherapy Market Share, By End User, By Value, 2019-2030
Figure 21 South India Cancer Immunotherapy Market Size, By Value (USD Billion), 2019-2030
Figure 22 South India Cancer Immunotherapy Market Share, By Type, By Value, 2019-2030
Figure 23 South India Cancer Immunotherapy Market Share, By Application, By Value, 2019-2030
Figure 24 South India Cancer Immunotherapy Market Share, By End User, By Value, 2019-2030
Figure 25 West India Cancer Immunotherapy Market Size, By Value (USD Billion), 2019-2030
Figure 26 West India Cancer Immunotherapy Market Share, By Type, By Value, 2019-2030
Figure 27 West India Cancer Immunotherapy Market Share, By Application, By Value, 2019-2030
Figure 28 West India Cancer Immunotherapy Market Share, By End User, By Value, 2019-2030
List of Tables
Table 1 India Cancer Immunotherapy Segmentation
Table 2 India Cancer Immunotherapy Market Value Chain Analysis
Table 3 Company Market Size Analysis, 2023
Table 4 India Cancer Immunotherapy Market Size, By Value (USD Billion), 2019-2030
Table 5 India Cancer Immunotherapy Market Share, By Type, By Value, 2019-2030
Table 6 India Cancer Immunotherapy Market Share, By Application, By Value, 2019-2030
Table 7 India Cancer Immunotherapy Market Share, By End User, By Value, 2019-2030
Table 8 India Cancer Immunotherapy Market Share, By Region, By Value, 2019-2030
Table 9 North India Cancer Immunotherapy Market Size, By Value (USD Billion), 2019-2030
Table 10 North India Cancer Immunotherapy Market Share, By Type, By Value, 2019-2030
Table 11 North India Cancer Immunotherapy Market Share, By Application, By Value, 2019-2030
Table 12 North India Cancer Immunotherapy Market Share, By End User, By Value, 2019-2030
Table 13 South India Cancer Immunotherapy Market Size, By Value (USD Billion), 2019-2030
Table 14 South India Cancer Immunotherapy Market Share, By Type, By Value, 2019-2030
Table 15 South India Cancer Immunotherapy Market Share, By Application, By Value, 2019-2030
Table 16 South India Cancer Immunotherapy Market Share, By End User, By Value, 2019-2030
Table 17 East India Cancer Immunotherapy Market Size, By Value (USD Billion), 2019-2030
Table 18 East India Cancer Immunotherapy Market Share, By Type, By Value, 2019-2030
Table 19 East India Cancer Immunotherapy Market Share, By Application, By Value, 2019-2030
Table 20 East India Cancer Immunotherapy Market Share, By End User, By Value, 2019-2030
Table 21 South India Cancer Immunotherapy Market Size, By Value (USD Billion), 2019-2030
Table 22 South India Cancer Immunotherapy Market Share, By Type, By Value, 2019-2030
Table 23 South India Cancer Immunotherapy Market Share, By Application, By Value, 2019-2030
Table 24 South India Cancer Immunotherapy Market Share, By End User, By Value, 2019-2030
Table 25 West India Cancer Immunotherapy Market Size, By Value (USD Billion), 2019-2030
Table 26 West India Cancer Immunotherapy Market Share, By Type, By Value, 2019-2030
Table 27 West India Cancer Immunotherapy Market Share, By Application, By Value, 2019-2030
Table 28 West India Cancer Immunotherapy Market Share, By End User, By Value, 2019-2030
Table 29 Astellas Pharma Inc. Company Overview
Table 30 Astellas Pharma Inc. Financial Overview
Table 31 AstraZeneca Company Overview
Table 32 AstraZeneca Financial Overview
Table 33 Bayer AG Company Overview
Table 34 Bayer AG Financial Overview
Table 35 Bristol-Myers Squibb Company Overview
Table 36 Bristol-Myers Squibb Financial Overview
Table 37 Lilly Company Overview
Table 38 Lilly Financial Overview
Table 39 F. Hoffmann-La Roche Ltd Company Overview
Table 40 F. Hoffmann-La Roche Ltd Financial Overview
Table 41 Merck & Co., Inc. Company Overview
Table 42 Merck & Co., Inc. Financial Overview
Table 43 Novartis AG Company Overview
Table 44 Novartis AG Financial Overview
Table 45 Pfizer Inc. Company Overview
Table 46 Pfizer Inc. Financial Overview
Table 47 Gilead Sciences, Inc Company Overview
Table 48 Gilead Sciences, Inc Financial Overview
Table 49 GSK plc Company Overview
Table 50 GSK plc Financial Overview
Table 51 Johnson & Johnson Company Overview
Table 52 Johnson & Johnson Financial Overview
Table 53 Sanofi Company Overview
Table 54 Sanofi Financial Overview

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings